Cannabis Use Disorder Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Cannabis Use Disorder Market is segmented By Treatment (Pharmacotherapy (Synthetic cannabinoids, CB1 receptor antagonists, Antidepressants, Other medications), Behavioral Therapies (Cognitive Behavioral Therapy (CBT), Motivational Enhancement Therapy (MET), Contingency Management (CM))), By Route of Administration (Oral, Transdermal, Inhalation, Sublingual), By End User (Hospitals, Specialty Clinics, Rehabilitation Centers, Homecare Settings), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned.

Cannabis Use Disorder Market is segmented By Treatment (Pharmacotherapy (Synthetic cannabinoids, CB1 receptor antagonists, Antidepressants, Other medi....

Cannabis Use Disorder Market Size

Market Size in USD

CAGR9.33%

Study Period	2024 - 2031
Base Year of Estimation	2023
CAGR	9.33%
Market Concentration	Medium
Major Players	Aelis Farma, Indivior, Pfizer, Corbus Pharmaceuticals, Zynerba Pharmaceuticals

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

Cannabis Use Disorder Market Analysis

The cannabis use disorder market is estimated to be valued at USD 1.64 Bn in 2024 and is expected to reach USD 3.06 Bn by 2031, growing at a compound annual growth rate (CAGR) of 9.33% from 2024 to 2031. With increasing legalization of cannabis for medical and recreational purposes, more people are gaining access and risk developing cannabis use disorder. This growing acceptance and access to cannabis is expected to significantly drive the growth of the cannabis use disorder market over the forecast period.

Cannabis Use Disorder Market Report Snapshots

Buy Now